Trial of Famotidine & N-Acetyl Cysteine for Outpatients With COVID-19
Status:
Terminated
Trial end date:
2021-06-02
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to assess the safety and toxicity profile of the combination of
famotidine and oral n-acetyl cysteine in adult outpatients with newly diagnosed SARS-CoV-2
infection.